期刊文献+

P27^(kipl)、CyclinD_1在膀胱癌中的表达及其意义 被引量:2

Expressions of P27^(kipl) and CyclinD_1 in urinary bladder cancer
在线阅读 下载PDF
导出
摘要 目的:通过检测P27kipl与CyclinD1在膀胱癌中的表达,以探讨两者在膀胱癌发生发展中的作用及其与临床病理特征的关系。方法:对80例标本进行SP免疫组织化学方法检测P27kipl、CyclinD1的表达水平,其中正常组织28例,膀胱癌组织52例。结果:P27kipl、CyclinD1在正常膀胱组织中的表达率和在膀胱癌组织中的表达差异均具有显著性(P<0.01)。P27kipl蛋白在低分化组中的表达水平显著低于高分化组(P<0.01)和中分化组(P<0.01),CyclinD1表达水平在低分化组中显著高于高分化组(P<0.01),在中、低分化组间差异无显著性(P>0.05)。P27kipl的表达与临床分期无关,而CyclinD1的表达与临床分期相关。P27kipl与CyclinD1的相互关系呈负相关。结论:P27kipl蛋白的低表达或缺失在膀胱癌的发生中起重要作用,是膀胱癌发生中的早期分子事件。CyclinD1的过表达参与了膀胱癌的发生,并与其发展密切相关,可作为评价预后的指标之一。膀胱癌的发生发展与P27kipl、CyclinD1蛋白的异常表达密切相关,联合测定P27kipl、CyclinD1蛋白的表达对膀胱癌的诊断、治疗有一定的指导意义,可作为膀胱癌诊断和预后评价的重要参数。 Objective To explore the roles of P27^kipl and CyclinD1 in the oncogenesis of urinary bladder cancer and the relationship between these two genes and the pathological characteristics of bladder cancer by detecting the expressions of P27^kipl and CyclinD1, Methods The levels of P27^kipl and CyclinD1 expression in 80 specimens (28 normal tissue, 52 bladder cancer tissue) were detected by SP immunohistochemistry, Results There was a significant difference in the P27^kipl and CyclinDl between the normal bladder tissue and the bladder cancer tissue ( P 〈 0. 01 ). The level of P27k^kipl expression in the poorly differentiated tissue was markedly lowered than that in the moderately or well-differentiated tissue ( P 〈 0, 01 ). The level of CyclinD1 expression in the poorly differentiated tissue was much higher than that in the well-differentiated tissue ( P 〈 0. 01 ) but there was little difference in the CyclinD1 between the poorly differentiated and medium-differentiated tissue ( P 〉 0. 05 ). The CyclinD1 expression was associated with the clinical stage whereas the P27^kipl expression was not. P27^kipl was negatively related to CyclinD1. Conclusion Low P27^kipl expression or loss of expression plays an important role in the oncogenesis of urinary bladder cancer and is an early molecular pattern in the procession. Overexpression of CyclinD1 is also involved in the occurrence of bladder cancer, associated with its progression, and can be an indication for the assessment of prognosis. The oncogenesis and progression of bladder cancer are closely related to the abnormal expressions of P27^kipland CyclinD1. Detection of P27^kipl plus CyclinD1 expression is of some significance in the diagnosis and treatment of urinary bladder cancer and may be an important parameter in the diagnosis and prognosis assessment of the malignancy.
出处 《实用医学杂志》 CAS 2006年第22期2607-2610,共4页 The Journal of Practical Medicine
关键词 膀胱肿瘤 免疫组织化学 P27P27^kipl CYCLIND1 Bladder neoplasm Immunohistochemistry P27^kipl CycoinD1
  • 相关文献

参考文献14

  • 1HARRIS A W, BODRUG S E, WARNCE B J,et al. CyclinD1 as the putative bcl-1 oncogene [J] . Curr Top Microbiol Immunol, 1995,194:347 - 353.
  • 2POLYAK K, LEE M H, ERDJUNMENTG-BROMAGE H, et al.Cloning of P27^kipl, a cyclin-depondent kinase inhibitor and potential mediator of extracelluar antimitogenic signal [J]. Cell, 1994,78 ( 1 ) :59 -61.
  • 3MASUDA M, HIRAKAWA N, NAKASHIMA T, et al. CyclinD1 overpression in primary hypophargngeal carcinomas [J] . Cancer,1996,73(3) :390 - 395.
  • 4HARVAT B L, SETH P, JETTEN A M. The role of p27^kipl in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cell [J]. Oncogene, 1997, 14(17) :2111 -2122.
  • 5CRAIG C, WERSTO R, KIM M, et al. A recombinant adenovirus expression p27kipl induces cycle arrest and loss of cyclin-CDK activity in human breast cancer cell [J]. Oncogene, 1997, 14(19): 2283 -2289.
  • 6FRANKE K H, MIKLOSI M, GOEBELL P, et al. Cyclin-dependent kinase inhibitor P27^kipl is expressed preferentially in early stages of urothelial carcinoma [J]. Urology,2000,56(4):689 -695.
  • 7SGAMBATO A, MIGALDI M, FARAGLIA B, et al. Loss of P27^kipl expression Correlatres with tumor grade and with reduced disease-free suivival in primary superficial bladder cancers [J]. Cancer Res, 1999,59(13) :3245 -3250.
  • 8TANAKA H,FUJII Y,HIRABAYASHI H, et al. Disruption of the RB pathway and cell-proliferative activity in non-small cell cancers [J].Int J Cancer, 1998,79(2) : 111 - 115.
  • 9OYAMA T, KASHIWABARA K, YOSHIMOTO K, et al. Frequent overexpression of the cyclinD1 oncogene in invasive lobttlar carcinoma of the breast [ J ]. Cancer Res, 1998,58 ( 13 ) : 2876 - 2880.
  • 10朱斌,姚晓平,杨甲梅,丛文铭.原发性肝细胞癌中细胞周期G1期相关基因Cyclin D1的表达及其临床病理学意义[J].肝胆外科杂志,1999,7(3):214-216. 被引量:11

共引文献10

同被引文献15

  • 1余东海,周四维,章慧平,叶章群.CK20及Cjun在膀胱肿瘤的表达和临床意义[J].临床泌尿外科杂志,2005,20(5):288-290. 被引量:11
  • 2Nadal A,Cardesa A. Molecular biology of laryngeal squamous cell carcinoma[ J ]. Virchows Arch ,2003,442 ( 1 ) : 1 - 7.
  • 3Ohtani N, Yamakoshi K, Takahashi A, et al. The pl61NK4a - RB pathway: molecular link between cellular senescence and tumor suppression [ J ]. Med Invest ,2004,51 ( 3/4 ) : 146 - 153.
  • 4Takeba Y, Kumai T, Matsumoto N, et al. Irinotecan activates P53 with its active metabolite,resuhing in human hepatocellular carci- noma apoptosis [ J ]. J Pharmacol Sci,2007,104 ( 3 ) : 232 - 242.
  • 5Bau DT,Tsai MH,Lo YL,et al. Association of P53 and p21 ( CD- KNIAZWAFI/C1PI) polymorphisms with oral cancer in Taiwan patients [ J ]. A nticancer Res, 2007,27 ( 3 B ) : 1559 - 1564.
  • 6Jung .IT, Kim DH, Kwak EK, et al. Clinical role of Bcl - 2, Bax, or P53 overexpression in Periph - eral T - cell lymphomas [ J ]. Ann Hematol, 2006,85 ( 9 ) :575 - 579.
  • 7Farazi PA,Glickman J, Homer J,et al. Cooperative interactitms of P53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression [ J ]. Cancer Res, 2006,66 ( 9 ) :4766 - 4773.
  • 8Moll R,Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with un2 usual properties and expression patterns [ J ]. Cell Biol, 1990,111 ( 2 ) : 567 - 580.
  • 9詹自力,苟欣._P27、cyclin D1及膀胱移行细胞癌中的表达及其临床意义[J].当代医学,2010,16(24):31-33. 被引量:3
  • 10曾文利.Cyclin D1在膀胱癌中的表达及意义[J].中国组织化学与细胞化学杂志,2011,20(4):354-357. 被引量:3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部